Name: | Description: | Size: | Format: | |
---|---|---|---|---|
564.02 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Small-for-gestational-age children have been associated with up to 20% delayed growth and delayed development, increased childhood morbimortality, and poor quality of life. Prepubertal growth hormone administration results in increased growth and musculoskeletal development. The present case report illustrates the negative impact of growth hormone disruption in a 6-year-old patient, resulting in impaired growth and development. Close clinical and laboratory monitoring is recommended for small-for-gestational-age children receiving growth hormone treatment, and family counselling should be encouraged.
Description
Keywords
growth hormone growth impairment small-for-gestational-age
Citation
Cominato L, Frascino A, Nascer e Crescer - Birth and Growth Medical Journal 2020;29(1): 47-50. doi:10.25753/BirthGrowthMJ.v29.i1.15101
Publisher
Centro Hospitalar Universitário do Porto